Skip to main content

Prof. Gary Walsh

Biography

Prof. Gary Walsh is Chair of Industrial Biotechnology at the University of Limerick, Ireland. He obtained BSc & PhD degrees from the National University of Ireland at Galway in 1986 and 1989, respectively and more recently a graduate diploma in academic practice from UL in 2009. Prior to joining the university in 1994 he held the following industrial positions: Senior research scientist, Alltech Ireland Ltd., Production manager, Bioniche pharmaceuticals, Research scientist, Olympus diagnostics.



His research and scholarship interests span enzyme and pharmaceutical biotechnology as well as curriculum design and he was the recipient of the university's special achievement in research award in 2006.


His 106 ‘class 1' publications include: 9 authored books, 2 edited books, 17 book chapters and 78 journal articles. In addition he has authored 94 refereed conference proceedings, 5 book reviews and 7 reports. Three of his books are international student biotechnology textbooks that have gone to second edition and for which Chinese and Japanese foreign language editions have been published.

He has participated in research grant proposal applications which have successfully secured €3.1 million in funding, of which his personal share is €1.7 million. He has supervised/continues to supervise 22 researchers (14 postgraduate & 8 post-doctoral). He has served as a research proposal evaluator for various scientific funding bodies in Ireland, Holland, Norway and the UK.

He has presented his work at 60 international conferences, which include 33 guest/keynote presentations. He has served as session/conference chairman at 6 international conferences and as a member of the scientific advisory panel for 12 international conferences conferences.


He has acted as external examiner for 13 PhD and 4 MSc research theses in various Irish institutions, as well for Monash university in Australia. He has/continues to serve as external examiner for undergraduate taught programs in 4 Irish Institutes of Technology and 2 Irish Universities.

He teaches various biotechnology modules in Limerick and was the recipient of the university's excellence in teaching award in 2003. He has served as course director, B.Sc. industrial biochemistry for 2 terms and as the University's (acting) dean, teaching & learning from August to December 2004. He has lectured on taught courses at the University of Grenoble, France, the University of Jyvaskla, Finland and the National University of Ireland at Galway.


He chaired the University of Limerick institutional committee preparing for the 2012 institutional quality review and was the main author of the associated Institutional Self Assessment Report.


He has served as (founding) editor, biotechnology section, of the European Journal of Pharmaceutics and Biopharmaceutics and as a member of the editorial boards of Biopharm. International, New Drugs and the Encyclopaedia of Industrial Biotechnology. He has also served as scientific secretary and as a member of the board of governors of the European Association of Pharmaceutical Biotechnology and is a former Fulbright research visiting professor at the University of Georgia, in the United States.

Research Interests

Enzyme biotechnology: The development of renewable sources of liquid fuels as an alternative to fossil fuels is receiving increasing global attention due environmental, economic and energy security concerns. The production of bioethanol from cellulose-based raw materials (e.g. grass, straw & wood) is at the forefront of this technology, but a major stumbling block is how to effectively degrade the cellulose to its glucose building blocks (the glucose is then fermented to ethanol, basically by brewing technology). A major ongoing focus of my research group is the identification and use of enzymes (proteins that speed up chemical reactions) derived from thermoacidophilic bacteria (bugs that grow best in boiling acid) to more efficiently achieve cellulose degradation (a process that currently usually entails the use of boiling acid). These enzymes are also academically interesting because they work best under such extreme conditions. An additional focus of my research group is to identify selected enzymes produced by acidophilic bugs which can be used as digestive supplements in humans or animals (working in the acidic environs of the stomach). For example, the identification of acid-active ‘lactase' enzymes to degrade milk lactose in the stomach, thereby alleviating lactose intolerance (which effects up to 75% of the world's adult population).


Pharmaceutical biotechnology (Biopharmaceuticals): Biopharmaceuticals are drugs (mainly proteins such as insulin and antibodies, but also pieces of DNA called ‘gene therapy' products) that are synthesized biologically (as opposed to chemically), usually via genetic engineering. These products are at the cutting edge of the pharmaceutical sector, recording sales of €107 billion in 2011. My research in this area focuses largely upon altering the method of manufacturing (bioprocessing) of these products in order to achieve manufacturing more economically and making it more environmentally friendly in the process (green pharmaceutical manufacturing) We also work on stabilizing such proteins by attaching a chemical called PEG to them, as well as on the identification & analysis of trends/ likely future directions in biopharmaceutical production systems/ products/regulatory science.

Curriculum design.
Curriculum design and development, particularly with reference to pharmaceutical biotechnology/ protein biotechnology.

Teaching Interests

A short description of the 3 core modules I teach is provided below, along with teaching quality indicators.
In addition to these I contribute to a first year introductory biochemistry module and to an introductory science module taught to our first year nursing students. I have or continue to lecture on taught biotechnology-related courses at the National University of Ireland, Galway, the University of Grenoble, France and the University of Jyvaskla, Finland. I have/continue to serve as external examiner for a total of 14 taught undergraduate and postgraduate biotechnology-related courses at University College Cork, Dublin City University and several Institutes of Technology.

BC 4903 (Biomolecules; second year undergraduate level)
The range of biomolecules; their structure, properties, functions & selected biotech applications.

BC 4705 (Industrial Biochemistry 1; second year undergraduate level)
Practical Aspects of Pharmaceutical Manufacture: (International Pharmacopoeia, GMP, Clean Rooms, CDS, Purified water & WFI. Product Flow Through the Facility and Associated Documentation. Validation.
Industrial enzymes and proteins; range, applications and selected case studies. the Environmental Protection Agency (EPA) and IPPC Licensing for biotechnology.


BC 4718 (Industrial Biochemistry 2; final year undergraduate level)
Animal cell culture. The drug development process & patenting. Regulatory route for new drugs in USA & EU and ICH. Patenting in biotechnology. Biopharmaceutical manufacture: Sources of biopharmaceuticals. Upstream processing. Downstream processing. Post translational modifications and their significance. Product QC and the range and significance of potential product impurities. Specific biopharmaceuticals; Case studies

Evidence of teaching Quality

Student Evaluation of Teaching (SET) results for Gary Walsh, as independently undertaken by the University's Centre for Teaching and Learning (CTL) over the last number of years.


Forth year module (assessed 2012) Overall teaching effectiveness; 5.0 out of 5.0

(BC 4718; to Galway students via Overall module effectiveness; 5.0 out of 5.0


videolink)



Forth year module (assessed 2012) Overall teaching effectiveness; 4.7 out of 5.0


(BC 4718; to UL students) Overall module effectiveness; 4.7 out of 5.0



Second year Module (assessed 2012) Overall teaching effectiveness; 4.7 out of 5.0


(BC 4705; small group teaching) Overall module effectiveness; 4.7 out of 5.0



Third year Module (assessed 2009) Overall teaching effectiveness; 5.0 out of 5.0

(BC 4705; small group teaching) Overall module effectiveness; 4.7 out of 5.0



Forth year module (assessed 2009) Overall teaching effectiveness; 5.0 out of 5.0


(BC 4718; small group teaching) Overall module effectiveness; 4.7 out of 5.0



Forth year module (assessed 2003) Overall teaching effectiveness; 4.9 out of 5.0

(BC 4708; Small group teaching): Overall module effectiveness; 4.7 out of 5.0



First year module (assessed 2003) Overall lecture effectiveness; 4.9 out of 5.0

(BC 4401; Small group teaching) Overall module effectiveness; not asked



Second year module (assessed 2003)Overall lecture effectiveness; 4.6 out of 5.0

(BC 4903; Large group teaching):Overall module effectiveness; 4.5 out of 5.0

Professional Activities

Education

  • 2009 University of Limerick - Graduate Diploma in Academic Practice
  • 1989 University College Galway - Ph.D.
  • 1986 University College Galway - B.Sc.

Award

  • 2006 - Special achievement in research award
  • 2003 - University of Limerick excellence in teaching award

Committee

  • 2004 International advisory committee, Pharma BioTec Europe 2004 conference,
  • 2002 Board of governors and executive committee, European Association of Pharma Biotechnology,
  • 2002 Scientific secretary, European Association of Pharma Biotechnology,

Employment

  • 1994 CES dept, UL. - Assistant lecturer
  • 1992 Alltech European Biosciences Research Centre - Senior research scientist
  • 1990 Vetrepharm Ireland - Production manager
  • 1989 Olympus diagnostics, Tulla. - Research scientist

Publications

Books

2014

Proteins. Biochemistry and Biotechnology, second edition
Walsh, G
(2014) Proteins. Biochemistry and Biotechnology, second edition
Chichester, UK : Wiley Blackwell

2008

Medical Product Regulatory Affairs
Tobin, J.J. and Walsh, G.
(2008) Medical Product Regulatory Affairs
Weinheim, Germany : Wiley Blackwell

2007

Teaching at college and university: effective strategies and key principles
Moore, S; Walsh, G; Risquez, A
(2007) Teaching at college and university: effective strategies and key principles
(Ed.) Maidenhead : Open University Press Maidenhead

2007

Pharmaceutical Biotechnology. Concepts and Applications
Walsh, G.
(2007) Pharmaceutical Biotechnology. Concepts and Applications
Chichester, UK : Wiley

2005

Directory of approved biopharmaceutical products
Spada, S; Walsh, G
(2005) Directory of approved biopharmaceutical products
USA : CRC press USA

2003

Biopharmaceuticals: Biochemistry & Biotechnology
Walsh, G
(2003) Biopharmaceuticals: Biochemistry & Biotechnology
Chichester : J. Wiley & sons Chichester

2002

Proteins; biochemistry and biotechnology
Walsh, G
(2002) Proteins; biochemistry and biotechnology
Chichester UK : J. Wiley & sons Chichester UK

1999

Biopharmaceuticals; an industrial perspective
Walsh, G
(1999) Biopharmaceuticals; an industrial perspective
Walsh, G. and Murphy, B(Ed.) Netherlands : Kluwer academic publishers Netherlands

1998

Biopharmaceuticals: Biochemistry & Biotechnology
Walsh, G
(1998) Biopharmaceuticals: Biochemistry & Biotechnology
Chichester : J. Wiley & sons Chichester

1994

Protein Biotechnology
Walsh, G; Headon, D
(1994) Protein Biotechnology
Chichester : J. Wiley & sons Chichester

Book Chapters

2013

Posttranslational modifications to improve biopharmaceuticals
Walsh, G
(2013) Posttranslational modifications to improve biopharmaceuticals
In Modern Biopharmaceuticals: recent success stories; Weinheim, Germany : Wiley Blackwell
DOI: 10.1002/9783527669417.ch20

2012

Drug approval in the European Union and United States
Walsh, G
(2012) Drug approval in the European Union and United States
In Pharmaceutical Biotechnology; Weinheim, Germany : Wiley Blackwell
DOI: 10.1002/9783527632909.ch11

2011

Drug approval in the European Union and the United States
Walsh, G
(2011) Drug approval in the European Union and the United States
In An introduction to molecular biotechnology, second edition; Weinheim, Germany : Wiley Blackwell

2010

The Degradation of Oligonucleotide-based Pharmaceutical Products by Selected Chemical Means
Robinson C., Walsh G. & O'Dwyer T.F.
(2010) The Degradation of Oligonucleotide-based Pharmaceutical Products by Selected Chemical Means
In Environmental Engineering & Sustainability,; South Africa : ATINER, SA pp. 349-363

2004

Drug approval in the European Union and the United States
Walsh, G
(2004) Drug approval in the European Union and the United States
In Applications of pharmaceutical biotechnology; pp. 201-210

1999

Biopharmaceuticals; an overview
Walsh, G
(1999) Biopharmaceuticals; an overview
In Biopharmaceuticals, an industrial perspective; pp. 1-34

1999

Biopharmaceutical regulatory affairs
Walsh, G
(1999) Biopharmaceutical regulatory affairs
In Biopharmaceuticals, an industrial perspective; pp. 289-310

1995

In-feed assay of enzymes by radial enzyme diffusion, recent developments and application to analysis in pelleted feed
Walsh, G
(1995) In-feed assay of enzymes by radial enzyme diffusion, recent developments and application to analysis in pelleted feed
In Biotechnology in the feed industry; pp. 331-336

1994

Registration of enzymes and biological products around the world; current analytical methods for feed enzymes and future developments
Power, RF; Walsh, G
(1994) Registration of enzymes and biological products around the world; current analytical methods for feed enzymes and future developments
In Biotechnology in the feed industry; pp. 117-126

1994

Biological control of pollution
Headon, DR; Walsh, G
(1994) Biological control of pollution
In Principles of pig science;

1993

Industrial enzyme applications; matching enzyme to substrate in animal feed
Sears, A; Walsh, G
(1993) Industrial enzyme applications; matching enzyme to substrate in animal feed
In Biotechnology in the feed industry; pp. 373-394

Edited Books

2009


(2009)
In Post-translational Modification of Protein Biopharmaceuticals; Walsh, Gary(Ed.) Germany : Wiley-Backwell

2006


(2006)
In Directory of Therapeutic Enzymes; McGrath, B. M. and Walsh, G.(Ed.) Boca Raton, Florida : CRC Press pp. 1-303

Peer Reviewed Journals

2013

Milestones and Moderate Progress in 2012 Drug Approvals
Walsh, G
(2013) Milestones and Moderate Progress in 2012 Drug Approvals
In Biopharm International; pp. 54-56

2012

A 25-year retrospective on the public's perception of the biopharmaceutical and biotech industry
Walsh, G and Ultee, M.
(2012) A 25-year retrospective on the public's perception of the biopharmaceutical and biotech industry
In Biopharm International; pp. 26-27

2012

Veterinary-based biopharmaceuticals
Ryan MP, Walsh G
(2012) Veterinary-based biopharmaceuticals
In Trends In Biotechnology;
DOI: 10.1016/j.tibtech.2012.08.005

2012

New Biopharmaceuticals
Walsh, G
(2012) New Biopharmaceuticals
In Biopharm International; pp. 34-36

2012

Identification of fungal proteases potentially suitable for environmentally friendly cleaning-in-place in the dairy industry
Boyce, A,Walsh, G
(2012) Identification of fungal proteases potentially suitable for environmentally friendly cleaning-in-place in the dairy industry
In Chemosphere; pp. 211-218
DOI: 10.1016/j.chemosphere.2012.03.022

2011

Stabilization of a supplemental digestive enzyme by post-translational engineering using chemically-activated polyethylene glycol
Turner, KM; Pasut, G; Veronese, FM; Boyce, A; Walsh, G
(2011) Stabilization of a supplemental digestive enzyme by post-translational engineering using chemically-activated polyethylene glycol
In Biotechnology Letters; pp. 617-621
DOI: 10.1007/s10529-010-0474-7

2010

The importance of and an approach to comprehensive reflective practice
Walsh, G.
(2010) The importance of and an approach to comprehensive reflective practice
In Biochemistry And Molecular Biology Education; pp. 1-3
DOI: 10.1002/bmb.20370

2010

Engineering of a fungal beta-galactosidase to remove product inhibition by galactose
Hu, XJ; Robin, S; O'Connell, S; Walsh, G; Wall, JG
(2010) Engineering of a fungal beta-galactosidase to remove product inhibition by galactose
In Applied Microbiology And Biotechnology; pp. 1773-1782
DOI: 10.1007/s00253-010-2662-8

2010

Post-translational modifications of therapeutic proteins
Walsh, G
(2010) Post-translational modifications of therapeutic proteins
In Drug Discovery Today; pp. 773-780
DOI: 10.1016/j.drudis.2010.06.009

2010

Utilisation of phosphorus nutrient content in industrial scale plasmid DNA production: a waste minimisation study
Cliffe, FE; Walsh, G; O'Dwyer, TF
(2010) Utilisation of phosphorus nutrient content in industrial scale plasmid DNA production: a waste minimisation study
In Journal Of Cleaner Production; pp. 1066-1072
DOI: 10.1016/j.jclepro.2010.02.013

2010

A novel acid-stable, acid-active beta-galactosidase potentially suited to the alleviation of lactose intolerance
O'Connell, S; Walsh, G
(2010) A novel acid-stable, acid-active beta-galactosidase potentially suited to the alleviation of lactose intolerance
In Applied Microbiology And Biotechnology; pp. 517-524
DOI: 10.1007/s00253-009-2270-7

2010

Assessment of the potential suitability of selected commercially available enzymes for cleaning-in-place (CIP) in the dairy industry.
Boyce A., Piterina A.V., Walsh G.
(2010) Assessment of the potential suitability of selected commercially available enzymes for cleaning-in-place (CIP) in the dairy industry.
In Biofouling; pp. 837-850
DOI: 10.1080/08927014.2010.522705

2010

Biopharmaceutical Approval Trends in 2009
Walsh, G
(2010) Biopharmaceutical Approval Trends in 2009
In Biopharm International; pp. 30-+

2010

Biopharmaceutical benchmarks 2010
Walsh, G
(2010) Biopharmaceutical benchmarks 2010
In Nature Biotechnology; pp. 917-924
DOI: 10.1038/nbt0910-917

2009

Biopharmaceuticals: Approval Trends in 2008
Walsh, G
(2009) Biopharmaceuticals: Approval Trends in 2008
In Biopharm International; pp. 68-+

2008

Application relevant studies of fungal beta-galactosidases with potential application in the alleviation of lactose intolerance
O'Connell, S; Walsh, G
(2008) Application relevant studies of fungal beta-galactosidases with potential application in the alleviation of lactose intolerance
In Applied Biochemistry And Biotechnology; pp. 129-138
DOI: 10.1007/s12010-007-8098-7

2008

Biopharmaceuticals: Approval Trends in 2007
Walsh, G
(2008) Biopharmaceuticals: Approval Trends in 2007
In Biopharm International; pp. 52-+

2007

Purification and characterisation of an acid phosphatase with phytase activity from Mucor hiemalis Wehmer
Boyce, A; Walsh, G
(2007) Purification and characterisation of an acid phosphatase with phytase activity from Mucor hiemalis Wehmer
In Journal Of Biotechnology; pp. 82-87
DOI: 10.1016/j.jbiotec.2007.08.028

2007

Protein engineering - Case studies of commercialized engineered products
Walsh, G
(2007) Protein engineering - Case studies of commercialized engineered products
In Biochemistry And Molecular Biology Education; pp. 2-8
DOI: 10.1002/bmb.21

2007

Approval trends in 2006
Walsh, G
(2007) Approval trends in 2006
In Biopharm International; pp. 56-+

2007

Purification and properties of a beta-galactosidase with potential application as a digestive supplement
O'Connell, S; Walsh, G
(2007) Purification and properties of a beta-galactosidase with potential application as a digestive supplement
In Applied Biochemistry And Biotechnology; pp. 1-13
DOI: 10.1007/s12010-007-9206-4

2007

Engineering biopharmaceuticals
Walsh, G
(2007) Engineering biopharmaceuticals
In Biopharm International; pp. 64-68

2007

Production, purification and application-relevant characterisation of an endo-1,3(4)-beta-glucanase from Rhizomucor miehei
Boyce, A; Walsh, G
(2007) Production, purification and application-relevant characterisation of an endo-1,3(4)-beta-glucanase from Rhizomucor miehei
In Applied Microbiology And Biotechnology; pp. 835-841
DOI: 10.1007/s00253-007-1058-x

2007

The pharmaceutical biotechnology content of pharmacy programs within Europe: A survey
Walsh G., Muller R.
(2007) The pharmaceutical biotechnology content of pharmacy programs within Europe: A survey
In Pharmacy Education; pp. 27-33
DOI: 10.1080/15602210601084366

2006

Physicochemical characteristics of commercial lactases relevant to their application in the alleviation of lactose intolerance
O'Connell, S; Walsh, G
(2006) Physicochemical characteristics of commercial lactases relevant to their application in the alleviation of lactose intolerance
In Applied Biochemistry And Biotechnology; pp. 179-191
DOI: 10.1385/ABAB:134:2:179

2006

Biopharmaceuticals: Approval trends in 2005
Walsh, G
(2006) Biopharmaceuticals: Approval trends in 2005
In Biopharm International; pp. 58-+

2006

Biopharmaceutical benchmarks 2006
Walsh, G
(2006) Biopharmaceutical benchmarks 2006
In Nature Biotechnology; pp. 769-U5
DOI: 10.1038/nbt0706-769

2006

Protein post translatioal modification in the context of biopharmaceuticals
Walsh, G and Jefferis, R.
(2006) Protein post translatioal modification in the context of biopharmaceuticals
In Nature Biotechnology; pp. 1241-1252

2006

Comparison of selected physicochemical characteristics of commercial phytases relevant to their application in phosphate pollution abatement
Boyce, A; Walsh, G
(2006) Comparison of selected physicochemical characteristics of commercial phytases relevant to their application in phosphate pollution abatement
In Journal Of Environmental Science And Health Part A-Toxic/Hazardous Substances & Environmental Engineering; pp. 789-798
DOI: 10.1080/10934520600614397

2005

Biopharmaceuticals: Approvals and approval trends in 2004
Walsh, G
(2005) Biopharmaceuticals: Approvals and approval trends in 2004
In Biopharm International; pp. 58-+

2005

Quantification of supplemental enzymes in animal feedingstuffs by radial enzyme diffusion
Walsh, G; Murphy, RA; Killeen, GF; Power, RF
(2005) Quantification of supplemental enzymes in animal feedingstuffs by radial enzyme diffusion
In Applied Microbiology And Biotechnology; pp. 70-74
DOI: 10.1007/s00253-004-1826-9

2005

A series of enzymology-based experiments designed to mimic an applied research project
Boyce, A; Walsh, G
(2005) A series of enzymology-based experiments designed to mimic an applied research project
In Biochemistry And Molecular Biology Education; pp. 420-425
DOI: 10.1002/bmb.2005.49403306420

2005

Biopharmaceuticals: recent trends and likely directions
Walsh, G
(2005) Biopharmaceuticals: recent trends and likely directions
In Trends In Biotechnology; pp. 553-558

2005

The use of proteases to remove protein-based residues from solid surfaces
Turner, K; Serantoni, M; Boyce, A; Walsh, G
(2005) The use of proteases to remove protein-based residues from solid surfaces
In Process Biochemistry; pp. 3377-3382
DOI: 10.1016/j.procbio.2005.03.040

2005

Scaling the biobusiness information mountain
Williams, G; Walsh, G
(2005) Scaling the biobusiness information mountain
In Nature Biotechnology; pp. 147-149
DOI: 10.1038/bioent836

2005

Therapeutic insulins and their large scale manufacture
Walsh, G
(2005) Therapeutic insulins and their large scale manufacture
In Applied Microbiology And Biotechnology; pp. 151-159

2004

Identification and characterization of a phytase of potential commercial interest
Casey, A; Walsh, G
(2004) Identification and characterization of a phytase of potential commercial interest
In Journal Of Biotechnology; pp. 313-322
DOI: 10.1016/j.jbiotec.2004.03.001

2004

A phytase enzyme-based biochemistry practical particularly suited to students undertaking courses in biotechnology and environmental science
Boyce, A; Casey, A; Walsh, G
(2004) A phytase enzyme-based biochemistry practical particularly suited to students undertaking courses in biotechnology and environmental science
In Biochemistry And Molecular Biology Education; pp. 336-340
DOI: 10.1002/bmb.2004.494032050392

2004

Thermostable phytase enzyme
Walsh G.
(2004) Thermostable phytase enzyme
In Industrial Bioprocessing; pp. 11-0

2004

Second generation biopharmaceuticals
Walsh, G
(2004) Second generation biopharmaceuticals
In European J. Pharmaceutics & Biopharmaceutics; pp. 185-196

2004

Modern antibody-based therapeutics
Walsh, G
(2004) Modern antibody-based therapeutics
In Biopharm International; pp. 18-+

2003

Pharmaceutical biotechnology products approved within the European Union
Walsh, G
(2003) Pharmaceutical biotechnology products approved within the European Union
In European J. Pharmaceutics & Biopharmaceutics; pp. 3-10

2003

Purification and characterization of extracellular phytase from Aspergillus niger ATCC 9142
Casey, A; Walsh, G
(2003) Purification and characterization of extracellular phytase from Aspergillus niger ATCC 9142
In Bioresource Technology; pp. 183-188
DOI: 10.1016/S0960-8524(02)00145-1

2003

Purification and characterization of an extracellular phytase from Aspergillus niger ATCC 9142
Casey, A; Walsh, G
(2003) Purification and characterization of an extracellular phytase from Aspergillus niger ATCC 9142
In Bioresource Technology; pp. 183-188

2003

Biopharmaceutical benchmarks - 2003
Walsh, G
(2003) Biopharmaceutical benchmarks - 2003
In Nature Biotechnology; pp. 865-870
DOI: 10.1038/nbt0803-865

2002

Biopharmaceuticals first versus second-generation products
Walsh, G
(2002) Biopharmaceuticals first versus second-generation products
In New Drugs; pp. 26-32

2002

Biopharmaceuticals and biotechnology medicines; an issue of nomenclature
Walsh, G
(2002) Biopharmaceuticals and biotechnology medicines; an issue of nomenclature
In European J. Pharmaceutical Sciences; pp. 135-138

2002

Eine neue generation von biopharmazeutika
Walsh, G
(2002) Eine neue generation von biopharmazeutika
In Labor Praxis; pp. 30-33

2001

Biopharmaceuticals
Walsh, G
(2001) Biopharmaceuticals
In New Drugs; pp. 58-61

2001

Core concepts suitable for education and training for the biopharmaceutical industry
Walsh, G
(2001) Core concepts suitable for education and training for the biopharmaceutical industry
In Drug Information Journal; pp. 985-991

2001

Monoclonal antibody based therapeutics
Walsh, G
(2001) Monoclonal antibody based therapeutics
In Pharmaceutical Technology Europe; pp. 70-76

2000

Biopharmaceutical benchmarks
Walsh, G
(2000) Biopharmaceutical benchmarks
In Nature Biotechnology; pp. 831-833
DOI: 10.1038/78720

2000

A suggested module detailing biopharmaceuticals suitable for inclusion in undergraduate biochemistry/applied biochemistry programmes
Walsh, G
(2000) A suggested module detailing biopharmaceuticals suitable for inclusion in undergraduate biochemistry/applied biochemistry programmes
In Biochemical Education; pp. 89-92

1999

A suggested postgraduate curriculum for education and training for the biopharmaceutical industry
Murphy, DB; Walsh, G
(1999) A suggested postgraduate curriculum for education and training for the biopharmaceutical industry
In Drug Information Journal; pp. 615-626

1999

Drug approval in Europe - The EMEA gets good grades, but has room for improvement
Walsh, G
(1999) Drug approval in Europe - The EMEA gets good grades, but has room for improvement
In Nature Biotechnology; pp. 237-240
DOI: 10.1038/6977

1998

A simple immunoassay-based system capable of detecting antibody raised against human IgG
Walsh, G; O'Shaughnessy, B; Shanley, N; Tobin, JJ
(1998) A simple immunoassay-based system capable of detecting antibody raised against human IgG
In Biochemical Education; pp. 157-160
DOI: 10.1016/S0307-4412(98)00049-1

1998

Antimicrobial Saponins of Yucca schidigera and the Implications of Their in Vitro Properties for Their in Vivo Impact
Killeen G.F., Madigan C.A., Connolly C.R., Walsh G.A., Clark C., Hynes M.J., Timmins B.F., James P., Headon D.R., Power R.F.
(1998) Antimicrobial Saponins of Yucca schidigera and the Implications of Their in Vitro Properties for Their in Vivo Impact
In Journal Of Agricultural And Food Chemistry; pp. 3178-3186

1997

Life in the hot stuff: Thermophilic microorganisms
Pembroke J.T., Walsh G., Adley C., O'Sullivan C.
(1997) Life in the hot stuff: Thermophilic microorganisms
In Biologist; pp. 353-355

1996

Biopharmaceuticals, the future
Walsh, G
(1996) Biopharmaceuticals, the future
In The Biologist; pp. 58-60

1996

Enzymes, the workhorses of biotechnology
Walsh, G; Adley, C; Pembroke, JT
(1996) Enzymes, the workhorses of biotechnology
In The Biologist; pp. 207-210

1995

Biopharmaceuticals, the bodie's own drugs
Walsh, G.
(1995) Biopharmaceuticals, the bodie's own drugs
In The Biologist; pp. 209-212

1995

Technical note: detection and quantification of supplemental beta glucanase activity in animal feed.
Walsh, G., Murphy, R., Killeen, G., Headon, D. and Power, R.
(1995) Technical note: detection and quantification of supplemental beta glucanase activity in animal feed.
In Journal Of Animal Science; pp. 1074-1076

1995

Nervous excitement over neurotrophic factors
Walsh G.
(1995) Nervous excitement over neurotrophic factors
In Nature Biotechnology; pp. 1167-1171

1994

The industrial production of enzymes.
Headon, D. and Walsh, G.
(1994) The industrial production of enzymes.
In Biotechnology Advances; pp. 636-646

1994

Enzymes in the animal feed industry
Walsh, G. Power, R. and Headon, D.
(1994) Enzymes in the animal feed industry
In Trends In Food Science & Technology; pp. 81-87

1994

Recombinant reproduction
DeKoning, W., Walsh, G., Wrenn, A., and Headon, D.
(1994) Recombinant reproduction
In Nature Biotechnology; pp. 988-992

1994

Influence of Yucca Shidigera preparations on the activity of urease from Bacillus pasteurii
Killeen, G., Buggle, K. Hynes. M., Walsh, G. Power, R. and Headon, D
(1994) Influence of Yucca Shidigera preparations on the activity of urease from Bacillus pasteurii
In Journal Of The Science Of Food And Agriculture; pp. 433-440

1993

Enzymes in the animal feed industry
walsh, G. Power, R. and Headon, D.
(1993) Enzymes in the animal feed industry
In Trends In Biotechnology; pp. 424-430

1993

An ultrafuiltration method for the removal of interfering agents and its application to the determination of free ammonia in solutons of oxystarch by the berthelot method
Killeen, J., Hynes, M., Power, R., Walsh, G and Headon, D.
(1993) An ultrafuiltration method for the removal of interfering agents and its application to the determination of free ammonia in solutons of oxystarch by the berthelot method
In Analytical Biochemistry; pp. 284-291

Conference Publications

2014

Environ 2014
Ryan, M. and Walsh, G.
(2014) Environ 2014

2014

Environ 2014
Boyce, A. and Walsh, G.
(2014) Environ 2014

2014

4th international congress on Green Process Engineering
Boyce, A. and Walsh, G.
(2014) 4th international congress on Green Process Engineering

2014

4th international congress on Green Process Engineering
Witt, M. O'Dwyer, T. and Walsh, G.
(2014) 4th international congress on Green Process Engineering

2012

Proceedings of the 5th international conference on sustainable energy and environmental protection
Boyce, A. and Walsh, G.
(2012) Proceedings of the 5th international conference on sustainable energy and environmental protection

2012

BIO World Congress on Industrial Biotechnology & Bioprocessing
Witt, M., O'Dwyer, T. and Walsh, G.
(2012) BIO World Congress on Industrial Biotechnology & Bioprocessing

2012

20th European Biomass Conference
Boyce, A. and Walsh, G.
(2012) 20th European Biomass Conference

2012

BIO World Congress on Industrial Biotechnology & Bioprocessing
Boyce, A. and Walsh, G.
(2012) BIO World Congress on Industrial Biotechnology & Bioprocessing

2012

Proceedings of the 5th international conference on sustainable energy and environmental protection
McKevitt, K. and Walsh, G.
(2012) Proceedings of the 5th international conference on sustainable energy and environmental protection

2012

Proceedings of the 5th international conference on sustainable energy and environmental protection
Witt, M. O'Dwyer, T. and Walsh, G.
(2012) Proceedings of the 5th international conference on sustainable energy and environmental protection

2012

Environ 2012
Boyce, A. and Walsh, G.
(2012) Environ 2012

2012

Proceedings of the 5th international conference on sustainable energy and environmental protection
Boyce, A. and Walsh, G.
(2012) Proceedings of the 5th international conference on sustainable energy and environmental protection

2012

the 8th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology
Walsh, G.
(2012) the 8th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology

2011

Pharmaceutical Regulatory Affairs
Walsh, G.
(2011) Pharmaceutical Regulatory Affairs

2011

Biotrends
Walsh, G.
(2011) Biotrends

2010

EPA National Research Conference 2010
Witt, M. O'Dwyer, T and Walsh, G.
(2010) EPA National Research Conference 2010

2010

Environ 2010
Witt, M. O'Dwyer, T. and Walsh, G.
(2010) Environ 2010

2010

Third Brazilian Biotechnology Congress
Walsh, G.
(2010) Third Brazilian Biotechnology Congress

2010

Third International Science to Market Conference
Walsh, G.
(2010) Third International Science to Market Conference

2010

EPA National Research Conference 2010
Robinson, C. Walsh, G. and O'Dwyer, T.
(2010) EPA National Research Conference 2010

2010

The international conference on environmental science and technology (ICEST 2010)
Robinson, C. Walsh, G. and O'Dwyer, T.
(2010) The international conference on environmental science and technology (ICEST 2010)

2010

EPA National Research Conference 2010
Boyce, A. ans Walsh, G.
(2010) EPA National Research Conference 2010

2010

5th Annual International Symposium on Environment
Robinson, C., Walsh, G. and O'Dwyer, T.
(2010) 5th Annual International Symposium on Environment

2010

15th International Pharmaceutical Technology Symposium
Walsh, G.
(2010) 15th International Pharmaceutical Technology Symposium

2010

EPA National Research Conference 2010
Walsh, G.
(2010) EPA National Research Conference 2010

2010

Environ 2010
Boyce, A. and Walsh, G.
(2010) Environ 2010

2010

15th International Pharmaceutical Technology Symposium
Walsh, G.
(2010) 15th International Pharmaceutical Technology Symposium

2009

Third Annual Biosimilars conference
Walsh, G
(2009) Third Annual Biosimilars conference

2009

Environ 2009
Cliffe, F., Walsh, G. and O'Dwyer, T.
(2009) Environ 2009

2009

Environ 2009
Boyce, A. and Walsh, G.
(2009) Environ 2009

2009

42nd IUPAC Congress
Boyce, A., Piterina, A. and Walsh, G.
(2009) 42nd IUPAC Congress

2009

Environ 2009
Robinson, C. , Walsh, G. and O'Dwyer, T.
(2009) Environ 2009